Ignite Creation Date:
2024-05-06 @ 7:37 PM
Last Modification Date:
2024-10-26 @ 3:10 PM
Study NCT ID:
NCT06079645
Status:
RECRUITING
Last Update Posted:
2023-10-23
First Post:
2023-10-06
Brief Title:
Lichen Sclerosus - Treatment With Triamcinolone Acetonide Injections Syringe and Needle x Micro Injections MMP Technique
Sponsor:
Clinica Dermatologica Arbache ltda
Organization:
Clinica Dermatologica Arbache ltda
Study Overview
Official Title:
Triamcinolone Acetonide Injections Compared With Micro Injections MMP Technique of Triamcinolone Acetonide for the Treatment of Female Genital Lichen Sclerosus and Atrophic
Status:
RECRUITING
Status Verified Date:
2023-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This research is about a genital disease known as Lichem Sclerosus and Atrophic It mainly affects women over 18 years of age The treatment will involve injections of a medicine that contains cortisone using two different methods with a syringe and a needle or with a tattoo machine Before and after treatment they will see if women feel pain itching burning scratching or difficulty having sexual intercourse
Detailed Description:
There is evidence that injectable triamcinolone has an effect on reducing the symptoms of lichen sclerosus and atrophic After randomizing the vulva the vulva will be anesthetized with lidocaine infiltrations After 15 minutes interventions will begin Triamcinolone will be injected using two different techniques syringes needles in one side and with tattoo machine MMP technique in other side The outcomes will be evaluated according to the criteria of pain itching burning itching and difficulty in sexual penetration
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
False
Is an FDA AA801 Violation?:
None